Alzheimer's disease

News

Closeup of X-ray photography of human brain

Merck swings back into Alzheimer's with $1.1bn Cerevance all...

Merck & Co's earlier efforts to find new therapies for Alzheimer's disease resulted in failure, but the company is returning to the field via an R&D alliance with UK biotech Cerevan

News

Conceptual image of a head with cog gears as brain.

AC Immune tries to resurrect crenezumab with new data delve

In May, another amyloid targeting drug for Alzheimer's disease – AC Immune and Roche's crenezumab – missed the mark in another clinical trial and looked destined for the scrap heap like so

R&D

For neurological disease, solving measurement is the first a...

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people worldwide, and their prevalence is only increasing, according to the World Health Organization.

News

AbbVie cuts Alzheimer's alliance with Alector in half

AbbVie is pulling out of its collaboration with Alector on the development of Alzheimer's disease candidate AL003, which aims to tackle the neurodegenerative disease by restoring reduced im

News

Eisai/Biogen could get FDA verdict on new Alzheimer's drug b...

The FDA has started an accelerated review of Eisai and Biogen's a new amyloid-targeting antibody lecanemab for Alzheimer's disease, with a 6 January deadline that keep them ahead of closest

News